Related Experiment Video
Updated: Jan 22, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
MicroRNA-based potential diagnostic, prognostic and therapeutic applications in triple-negative breast cancer
Qian Tang1, Hu Ouyang1, Dongxiu He1,2
1a Institute of Pharmacy and Pharmacology, University of South China , Hengyang , Hunan , China.
Abstract:
Triple-negative breast cancer (TNBC) is a distinct subtype of breast cancer characterized by high recurrence rates and poor prognosis compared to other breast cancers. MicroRNAs (miRNAs) are small non-coding RNAs that regulate the expression of various post-transcriptional gene and silence a broad set of target genes. Many recent studies have demonstrated that miRNAs play an important role in the initiation, promotion, malignant conversion, progression, and metastasis of TNBC. Therefore, the aim of this review is to focus on recent advancements of microRNAs-based potential applications in diagnosis, treatment and prognosis of triple-negative breast cancer.
Insights
Triple-negative breast cancer (TNBC) shows poor prognosis. MicroRNAs (miRNAs) are key in TNBC development and progression, offering potential for new diagnostic and therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Triple-negative breast cancer (TNBC) presents a significant clinical challenge due to high recurrence rates and limited treatment options.
- MicroRNAs (miRNAs) are critical regulators of gene expression involved in various cellular processes.
- Emerging evidence highlights the crucial role of miRNAs in TNBC initiation, progression, and metastasis.
Purpose of the Study:
- To review recent advancements in the application of microRNAs for triple-negative breast cancer.
- To explore the potential of miRNAs in the diagnosis, treatment, and prognosis of TNBC.
Main Methods:
- Literature review of recent studies on microRNAs and triple-negative breast cancer.
- Analysis of miRNA involvement in TNBC pathogenesis.
- Evaluation of miRNA-based diagnostic and therapeutic strategies.
Main Results:
- MicroRNAs are implicated in the initiation, promotion, malignant conversion, progression, and metastasis of TNBC.
- Specific miRNAs show potential as biomarkers for TNBC diagnosis and prognosis.
- miRNA-based therapies are being investigated for their efficacy in treating TNBC.
Conclusions:
- MicroRNAs represent a promising avenue for improving the diagnosis and treatment of triple-negative breast cancer.
- Targeting miRNAs could offer novel therapeutic strategies to combat TNBC.
- Further research into miRNA functions and applications is crucial for clinical translation in TNBC.
Related Concept Videos
MicroRNAs
MicroRNAs
Scalar and Vector Triple Products
The scalar triple product is the dot product of a vector with the cross product of two vectors....
Cardiovascular Drugs: Classification based on Therapeutic Indications
Negative Regulator Molecules
The Resting Membrane Potential

